HERB DRUG INTERACTIONS: CHALLENGES FOR CANCER PATIENTS UNDERGOING CHEMOTHERAPY

Main Article Content

Rajni Yadav
Amit Roy
Trilochan Satapathy

Keywords

Cancer, anticancer agents, complementary medicines, therapeutic activity

Abstract

Almost all societies have utilized medicinal herbs as a source of treatment. For thousands of years, people have utilized medicinal herbs to cure illnesses, preserve food, and enhance its flavor. Over the ages, human groups have shared knowledge of their therapeutic qualities with one another. Although modern scientific medicine has made great strides, traditional medicine remains the primary means of treating diseases for the majority of people in developing countries, including India. Even among those who have access to western medicine, the number of people using complementary and alternative medicine is still high. Active compounds produced during secondary metabolism are typically responsible for the biological properties of plant species used throughout the globe for various purposes, including treatment of chronic diseases. According to epidemiological data, nutrition has a significant impact on both human health and the management of a number of chronic illnesses, such as cancer. Certain medicinal herbs have antitumor chemicals, which make them potential candidates for chemotherapy preventive agents against the development of cancer. However, on occasion, these agents may react with the active ingredient and alter the therapeutic property's potency. In this study, an attempt has been made to draw attention to the possible interactions between the active substances and herbal components.

Abstract 162 | pdf Downloads 71

References

Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol 2004; 160: 339–49.
2. Timbo BB, Ross MP, McCarthy PV, Lin CT. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc 2006; 106: 1966–74.
3. Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc 2008; 108: 483–94.
4. Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006; 166: 1968–74.
5. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287: 337–44.
6. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans’ views on the use and regulation of dietary supplements. Arch Intern Med 2001; 161: 805–10.
7. Palmer ME, Haller C, McKinney PE et al. Adverse events associated with dietary supplements: an observational study. Lancet 2003; 361: 101–6.
8. Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007; 27: 1237–47.
9. Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med 2008; 14: 1263–9.
10. Kemper KJ, Amata-Kynvi A, Dvorkin L et al. Herbs and other dietary supplements: healthcare professionals’ knowledge, attitudes, and practices. Altern Ther Health Med 2003; 9: 42–9.
11. Suchard JR, Suchard MA, Steinfeldt JL. Physician knowledge of herbal toxicities and adverse herb-drug interactions. Eur J Emerg Med 2004; 11: 193–7.
12. Coxeter PD, McLachlan AJ, Duke CC, Roufogalis BD. Herb-drug interactions: an evidence based approach. Curr Med Chem 2004; 11: 1513–25.
13. Silverstein DD, Spiegel AD. Are physicians aware of the risks of alternative medicine? J Community Health 2001; 26: 159–74.
14. Zeolla MM, Cerulli J. Use of and familiarity with dietary supplement information references by practicing pharmacists. J Am Pharm Assoc 2008; 48: 401–4.
15. Miller LG, Hume A, Harris IM et al. White paper on herbal products. American College of Clinical Pharmacy. Pharmacotherapy 2000; 20: 877–91.
16. Cassileth BR. Herb-Drug Interactions in Oncology. Lewiston, NY: BC Decker, Inc., 2003.
17. Gaby AR. A-Z Guide to Drug-Herb-Vitamin Interactions. New York: Three Rivers Press, 2006.
18. Mahady GB. Botanical Dietary Supplements: Quality, Safety and Efficacy. Lisse, The Netherlands: Swets & Zeitlinger Publishers, 2001.
19. Mason P. Dietary Supplements. London: Pharmaceutical Press, 2001.
20. Tatro DS. Drug Interaction Facts. Saint Louis: Wolters Kluwer Health/Facts & Comparisons, 2010.
21. Ulbricht CE. Natural Standard Herbs & Supplement Reference: Evidence-Based Clinical Review. St Louis, MO: Mosby/Elsevier, 2005.
22. National Center for Complementary and Alternative Medicine. Herbs at a Glance Office of Dietary Supplements. Dietary Supplement Fact Sheets.
23. Ernst E. Herbal medicinal products during pregnancy: are they safe? Br J Obstet Gynaecol 2002; 109: 227–35.